Literature DB >> 3924066

Identification and quantitation of alpha 2-HS-glycoprotein in the mineralized matrix of calcified plaques of atherosclerotic human aorta.

F W Keeley, E E Sitarz.   

Abstract

alpha 2-HS-glycoprotein (HSGP) is a minor constituent of plasma with negative acute-phase reactant properties. HSGP has been shown previously to accumulate in the mineralized matrix of bone and dentin to concentrations substantially higher than those present in plasma. In addition, HSGP has also been found in experimentally induced dermal calcifications in animals. Here we show that HSGP is occluded in the organic matrix of pathological calcifications of atherosclerotic human aortic tissue in a concentration approximately 7-fold greater than that found in plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924066     DOI: 10.1016/0021-9150(85)90166-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.

Authors:  Motoki Osawa; Wei Tian; Hidekazu Horiuchi; Mika Kaneko; Kazuo Umetsu
Journal:  Hum Genet       Date:  2004-12-09       Impact factor: 4.132

2.  Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)).

Authors:  Vihas T Vasu; Brad Hobson; Kishorchandra Gohil; Carroll E Cross
Journal:  FEBS Lett       Date:  2007-03-15       Impact factor: 4.124

3.  Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells.

Authors:  Yana Dautova; Diana Kozlova; Jeremy N Skepper; Matthias Epple; Martin D Bootman; Diane Proudfoot
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

Review 4.  Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.

Authors:  Ciprian N Silaghi; Tamás Ilyés; Adriana J Van Ballegooijen; Alexandra M Crăciun
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.